About ibidi

ibidi is a leading partner for scientists in cell microscopy worldwide. Its extensive product range of µDishes, µ-Slides, and µ-Plates covers traditional cell cultivation in 2D and 3D as well as complex cellbased assays for the investigation of angiogenesis, chemotaxis, and wound healing. In addition, ibidi has an extensive expertise in solutions for the incubation and perfusion of cells.

Scientific institutions, industrial pharmacology, and the biotechnology industry worldwide rely on ibidi's products to advance disease research and therapy.

ibidi is headquartered in Gräfelfing, Germany, near Munich. The US headquarters, ibidi USA Inc. is located in Fitchburg, Wisconsin. The shared passion of all ibidi employees for innovation, quality and service and the close relationship with customers are the key to ibidi's excellence and success.

The impact of ibidi products on the global application of science is highlighted in more than 37,000 peer-reviewed publications. Currently, more than 10 peer-reviewed articles are published daily citing the use of ibidi products. In addition, there are now over 5000 patents using ibidi products.

Facts about ibidi
  • Founding: 2001
  • Focus : Manufacturer
  • Employees: 51-200
  • Industry : Laboratory equipment / supplies

News about ibidi

Here you will find ibidi GmbH

See the theme worlds for related content

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

3 whitepaper
View topic world
Topic world Cell culture technology

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

3 whitepaper

Topic World Cell Analysis

Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.

10+ products
5+ whitepaper
10+ brochures
View topic world
Topic World Cell Analysis

Topic World Cell Analysis

Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.

10+ products
5+ whitepaper
10+ brochures

Last viewed contents

Forschungszentrum Jülich GmbH - Jülich, Germany

Forschungszentrum Jülich GmbH - Jülich, Germany

Tumor diagnostics: AI model detects more than 170 types of cancer - Looking into the genome instead of into the tissue

Tumor diagnostics: AI model detects more than 170 types of cancer - Looking into the genome instead of into the tissue

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery - Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery - Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success

Whatman™ folded filter papers | Filter papers | Cytiva

Whatman™ folded filter papers | Filter papers | Cytiva

Start-up aims to harness the natural powers of cancer survivors to cure this life-threatening disease - Cure51 raises a €15 million seed round

Start-up aims to harness the natural powers of cancer survivors to cure this life-threatening disease - Cure51 raises a €15 million seed round

“And the Science Awards go to…” - Bayer Foundation announces Science Awards winners of 2024

“And the Science Awards go to…” - Bayer Foundation announces Science Awards winners of 2024

Supervisory Board of Bayer AG extends contract of CEO Bill Anderson - Far-reaching transformation advancing, delivering first signs of success

Supervisory Board of Bayer AG extends contract of CEO Bill Anderson - Far-reaching transformation advancing, delivering first signs of success

VTU Group appoints Liam O'Neil as new CEO

VTU Group appoints Liam O'Neil as new CEO

Dr. Wolf-Henning Walther becomes new CEO at Metrohm Germany - Change in the Executive Board from September 1, 2025

Dr. Wolf-Henning Walther becomes new CEO at Metrohm Germany - Change in the Executive Board from September 1, 2025

Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

Pioneers of epigenetics receive the Paul Ehrlich and Ludwig Darmstaedter Prize 2026 - The prizewinners' discovery shook the foundations of classical genetics and opened the door to the vast field of modern epigenetics

Pioneers of epigenetics receive the Paul Ehrlich and Ludwig Darmstaedter Prize 2026 - The prizewinners' discovery shook the foundations of classical genetics and opened the door to the vast field of modern epigenetics

Melina Schuh honored with Science Breakthrough 2025 - “It has always been my dream to make the entire ovulation process visible”

Melina Schuh honored with Science Breakthrough 2025 - “It has always been my dream to make the entire ovulation process visible”